text.skipToContent text.skipToNavigation
Need help? Please contact us
  1. Home
  2. %22t-vivo%22

You searched for "%22t-vivo%22"

32 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • D-HBE-As – Diseased Human Bronchial/Tracheal Epithelial Cells – Asthma
    D-HBE-As – Diseased Human Bronchial/Tracheal Epithelial Cells from donors having Asthma
    Catalog #: 00194911
    Sales unit: Ampule
    Compare
    AMP
  • Human Cryo Kupffer Cells, 0.2 Million

    Naïve Kupffer cells derived from human liver tissue. 0.2 million cells per vial

    Catalog #: HLKC-200K
    Sales unit: Ampule
    Compare
    AMP
  • Human Cryo Kupffer Cells, 0.5 Million

    Naïve Kupffer cells derived from human liver tissue. 0.5 million cells per vial.

    Catalog #: HLKC-500K
    Sales unit: Ampule
    Compare
    AMP
  • X-VIVO<sup>TM</sup> 10 Serum-free Hematopoietic Cell Medium
    X-VIVO™ 10, Serum free hematopoietic cell medium, with L-Glutamine, gentamicin and phenol red, xenofree, 1 L
    Catalog #: BE04-380Q
    Sales unit: each
    Compare
    EA
  • NHEK-Neo – Human Epidermal Keratinocytes – Neonatal, Single Donor

    Cryopreserved ampule of Neonatal Normal Human Epidermal Keratinocytes (NHEK-Neo), Single Donor, containing ≥ 500,000 cells

    Catalog #: 00192907
    Sales unit: each
    Compare
    EA
  • NHEK-Neo – Human Epidermal Keratinocytes, Neonatal, Pooled

    Cryopreserved Human Neonatal Epidermal Keratinocytes, Pooled, ≥ 500,000 cells

    Catalog #: 00192906
    Sales unit: each
    Compare
    EA
  • NHEK-Ad - Human Epidermal Keratinocytes, Adult, Single Donor

    Cryopreserved Human Adult Epidermal Keratinocytes (NHEK-Ad) from a single donor, ≥ 500,000 cells

    Catalog #: 00192627
    Sales unit: each
    Compare
    EA
  • TheraPEAK<sup class=reg>®</sup> LV Nucleocuvette<sup class=reg>®</sup> Cartridge, weldable (5 pcs)

    For use in combination with TheraPEAK® Nucleofector® Solution Sets, supporting the use of the 4D-Nucleofector®  LV Unit in a GMP environment.

    Catalog #: G4LN-7520W
    Sales unit: items
    Compare
    ST
  • 4D-Nucleofector<sup class=reg>®</sup> LV Unit

    For closed, scalable large-scale transfection of up to 1x109 cells.

    Catalog #: AAF-1002L
    Sales unit: items
    Compare
    ST
  • TheraPEAK<sup class=reg>®</sup> P3 Primary Cell Nucleofector<sup class=reg>®</sup> Solution Set (22.5 mL + 5 mL)

    For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.

    Catalog #: G4LP3-22500
    Sales unit: items
    Compare
    ST
  • TheraPEAK<sup class=reg>®</sup> 4D-Nucleofector<sup class=reg>®</sup> LV Reservoirs, weldable (5 pcs)
    For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
    Catalog #: G4LR-1501W
    Sales unit: items
    Compare
    ST
  • TheraPEAK<sup class=reg>®</sup> P3 Primary Cell Nucleofector<sup class=reg>®</sup> Solution Set (126 mL + 28 mL)

    For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.

    Catalog #: G4LP3-126000
    Sales unit: items
    Compare
    ST
  • 1
  • 2(current)

You searched for "%22t-vivo%22"

534 Documents found
  • Part III - Endotoxin Test Concerns of Biologics: LER From a Broad Biologics Test Perspective
    K. Williams, APR Nov/Dec 2015, pp 16-22.
  • References - X-Vivo™
    Overview of relevant references
  • TechSheet - X-VIVO™ Media Systems
    Instructions for how to use the X-VIVO™ Media Series
  • Primary Normal Human Cells and Media
    In Vivo Relevance. In Vitro Results. Updated and revised cell content.
  • TheraPEAK® X-VIVO® Hematopoietic Cell Culture Medium
    Serum-free, GMP produced medium for cell therapy applications
  • Non-viral Gene Modification for Ex-vivo Cell Therapy
    In this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
  • TheraPEAK® T-VIVO® Cell Culture Medium – Overview
    View or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
  • Terms and Conditions TheraPEAK T-VIVO Sample Request Program
  • 4D-Nucleofector® LV Unit for Large-scale Transfection
    Efficient, closed and scalable transfection for ex vivo cell and gene therapy applications
  • Instructions for Use - TheraPEAK® T-VIVO® Cell Culture Medium
    Instructions for how to use the TheraPEAK® T-VIVO® Cell Culture Media Series
  • Serum-free Media FFM Part Codes
    2019 change of all RUO Media to FFM production overview of RUO and new FFM part codes (X-VIVO not included)
  • NK Cell Assay using 3D Bioprinted Tumor Models
    This white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
  • A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell Expansion
    This poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.
  • Modeling a 3D respiratory model with the Quasi Vivo® QV600 Fluidic Cell Culture System
    In this Technical Note, we provide detailed information of how the Quasi Vivo® QV600 System was set up for the ALI culture of normal human bronchial or small airway epithelial (NHBE, SAE) cells.
  • Non-Viral Methods for Ex vivo Cell and Gene Therapy – Is the Future Non-viral?
    Learn from this interview about the types and benefits of non-viral methods for ex vivo cell and gene therapy as well as the readiness of electroporation-based technologies for use in GMP manufacturing.
  • A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]
    Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System
  • Clonetics™ and Poietics™ Disease Cells
    In Vivo Relevance. In Vitro Results. Product listings on Poster Six disease cell lines are identified:Airway, Skeletal Muscle,Adipose, Cardiac, Renal and Dermal
  • Fast-Track Development of an In Vitro 3D Lung/Immune Cell Model Using the Quasi Vivo® System
  • Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity Assay
    Protocol instructions
  • A Novel in vitro Liver Cell Culture Flow System Allowing Long-term Metabolism and Hepatotoxicity Studies
    Lonza Scientific poster. Here we present an alternative in vitro model that is based on the long-term culture of PHH in the Quasi Vivo® QV900 flow system.
  • 1(current)
  • 2
  • 3